|
The Registered Behavior Technician (RBT) credential is still an important step for people who want to work in Applied Behavior Analysis (ABA). The Behavior Analyst Certification Board (BACB) oversees the certification process to make sure that technicians have the skills … Continue reading
|
Antibody-Drug Conjugates in Oncology Pipeline Leading companies working in the Antibody-Drug Conjugates in Oncology market are Jiangsu Hengrui Medicine Co., Bio-Thera Solutions, MediLink Therapeutics, Byondis, AbbVie, Oxford BioTherapeutics, Iksuda Therapeutics, Novelty Nobility, LegoChem Biosciences, DualityBio, Lepu Biopharma, Ambrx, CSPC ZhongQi … Continue reading
|
|
Personal Care Contract Manufacturing Market Leading Personal Care Contract Manufacturing companies operating in this market include Albea Group, McBride, Colep Consumer Products, PLZ Corp., Voyant Beauty, Formula Corp., INTERCOS S.P.A., H.S.A. Hair Styling Applications S.p.A., Clarion Cosmetics, COMECER S.p.A., Novo … Continue reading
|
Dry Eye Disease Market Leading companies advancing innovative therapies in Dry Eye Disease (DED) include Palatin Technologies, Aldeyra Therapeutics, ReGenTree / RegeneRx Biopharmaceuticals, Mimetogen, Alcon / Aerie Pharmaceuticals, BRIM Biotechnology, Seikagaku Corporation, Mitotech, Senju Pharmaceutical, Sylentis / PharmaMar, Stuart Therapeutics, … Continue reading
|
|
Desmoid Tumors Market Leading Desmoid Tumors companies include SpringWorks Therapeutics, Immunome / Ayala Pharmaceuticals, Iterion Therapeutics, Eisai, PRISM BioLab, MedPacto, Inc., Pfizer, Novartis, Aadi Bioscience, Inc., INSYS Therapeutics Inc, Recursion Pharmaceuticals Inc, among others actively engaged in advancing therapeutic innovation. … Continue reading
|
Radiofrequency Ablation Devices Market DelveInsight’s New Report Reveals 11.16% CAGR Growth, Spotlighting AI Integration, Key Players, and Regional Dynamics Reshaping Global Radiofrequency Ablation DelveInsight Business Research LLP, a premier life sciences market research and consulting firm, today announced the release … Continue reading
|
|
Aducanumab Market Aducanumab received accelerated approval for early-stage Alzheimer’s disease, including mild cognitive impairment (MCI) due to AD and mild AD dementia. The approval was based on its demonstrated ability to reduce amyloid plaques, a surrogate endpoint under the amyloid … Continue reading
|
Aficamten Sales Market Aficamten’s growth is primarily driven by strong unmet need in symptomatic obstructive hypertrophic cardiomyopathy (oHCM), compelling Phase III efficacy data, and its next-generation cardiac myosin inhibition profile. Predictable pharmacokinetics, rapid reversibility, and simplified dosing position it for … Continue reading
|
|
FYLNETRA Sales FYLNETRA’s growth is driven by accelerating biosimilar adoption in oncology supportive care, payer-led switching from branded pegfilgrastim, and strong formulary inclusion across U.S. hospitals and infusion centers. Coherus’ focused commercial execution, contracting strategies, and engagement with oncology networks … Continue reading
|
Eosinophilic Esophagitis Market Eosinophilic Esophagitis Companies are Ellodi Pharmaceuticals, AstraZeneca, Regeneron Pharmaceuticals, Sanofi, Bristol-Myers Squibb, Allakos, EsoCap AG, Pfizer, Ception Therapeutics, Celgene, Dr. Falk Pharma GmbH, Revolo Biotherapeutics, Shire, Novartis, EMS, Celgene, Oxagen Ltd, Meritage Pharma, Inc, Forest Laboratories, and … Continue reading
|
